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Vitamin D Deficiency 
Background  
1. Definitions  
o Vitamin D is a fat-soluble vitamin  
o Vitamin D deficiency is measured by low circulating levels of 25-OH 
vitamin D in the serum 
 
Pathophysiology 
1. Absorption and metabolism  
o 2 main sources of Vitamin D  
 Vitamin D3 (cholecalciferol) - activated in skin by UV light 
 Vitamin D2 (ergocalciferol) - ingested form 
o Vitamin D is hydroxylated in liver to 25-OH Vitamin D (calcidiol)  
 Best serum marker of vitamin D sufficiency 
o Calcidiol is hydroxylated in kidney to 1,25-OH Vitamin D (calcitriol)  
 Most biologically active form 
2. Normal physiology  
o Vitamin D  
 Facilitates intestinal absorption of calcium and phosphate 
 Acts mainly in upper small intestine 
 Enhances renal reabsorption of phosphate 
 Aids in mineralization of bone 
 Plays a major part in homeostasis of calcium and phosphate  
o Calcium metabolism  
 Ionized calcium in ECF is maintained in a very narrow range 
 Low serum calcium stimulates PTH release from parathyroid glands 
 PTH encourages calcium resorption from bone and decreases calcium 
excretion from kidneys 
 PTH stimulates production of 1,25-OH Vitamin D in the kidney, which 
in turn increases intestinal calcium absorption 
 Elevated serum calcium suppresses PTH and Vitamin D production 
3. Pathology of disease  
o Decreased vitamin D leads to  
 Reduced absorption of calcium if Vitamin D deficiency is moderate - 
severe 
 Hypocalcemia may lead to decreased bone mineralization, muscle 
cramps, spasm, tetany, seizures, confusion, encephalopathy, 
papilledema, and QT prolongation 
 Stimulated release of PTH  
 Stimulates resorption of calcium from bone  
 Decreased resorption of phosphate in the kidney 
o Elevated vitamin D levels  
 Rare, seen mostly due to over-supplementation 
 May lead to hypercalcemia and hypercalciuria 
4. Incidence and prevalence  
o Certain patient groups at high risk for Vitamin D deficiency 
o Children  
 Among 618 Asian children in UK, 27% were vitamin D deficient  
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o Elderly  
 In homebound elderly, 54% prevalence in community dwellers and 
38% in nursing home residents  
o Hospitalized patients  
 57% of patients on a general medical service  
 Subgroup of patients with no known risk factors had 42% prevalence 
 Women treated for osteoporosis 
 52% of community-dwelling women were also Vitamin D deficient  
 Chronic renal disease 
 28-58% Vit D deficiency in patients with decreased GFR  
 Gastrointestinal disease 
 Healthy adults in winter 
 36% of healthy adults residing in Boston demonstrated Vitamin D 
deficiency at the end of winter as opposed to only 4% at the end of 
summer  
5. Risk factors  
o Inadequate sun exposure  
 Infants 
 Decreased sun exposure  
 Breast milk is poor source of Vitamin D 
 Formula supplementation only adequate if >1 L consumed daily 
 Persons residing at northern latitudes 
 Elderly  
 Indoor confinement 
 Skin of those older than 70 does not convert vitamin D effectively 
 Poor vitamin D intake 
o Inadequate dietary intake  
 Vitamin D found naturally in fatty fish, cod liver oil, and small amounts 
in eggs, butter, cheese 
 Commercial milk and cereals fortified with Vit D, but amounts may be 
inconsistent 
o Malabsorption  
 Fat malabsorption, steatorrhea  
 Celiac disease, cystic fibrosis 
o 5 hydroxylase deficiency 
o Increased catabolism  
 Vitamin D catabolized in liver by p450 system 
 Catabolism accelerated by phenytoin, phenobarbital, alcohol 
o End-organ resistance  
 Hereditary vitamin D resistant rickets 
6. Morbidity/ mortality  
o Inadequate treatment can lead to:  
 Osteomalacia (rickets in children) 
 Associated hypocalcemia may result in osteoporosis, fractures, seizures  
 Some evidence of increased all-cause mortality among elderly  
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Diagnostics 
1. History  
o Dietary intake – cod liver oil, fatty fish, egg yolks, cheese, supplemented 
milk and cereals 
o Sun exposure / sunscreen use 
o Mostly asymptomatic 
o Moderate to severe deficiency may result in non-specific musculoskeletal 
pain  
 Has been identified in patients with no known risk factors for Vitamin 
D deficiency  
 Vitamin D replacement may not improve pain symptoms  
2. Physical exam  
o No findings specific to vitamin D deficiency 
3. Diagnostic testing - Decreased serum 25-OH vitamin D  
o Laboratory evaluation: assays may vary, making exact measures difficult to 
define  
 Optimal levels 30-40 ng/ml (75-100 nmol/L)  
 Mild vitamin D deficiency 10-20 ng/ml (25-50 nmol/L) 
 Increased PTH production and bone turnover 
 Moderate vitamin D deficiency 5-10 ng/ ml (12.5-25 nmol/L) 
 High bone turnover, reduced bone density, increased risk hip fracture 
 Severe vitamin D deficiency <5 ng/ml (<12.5 nmol/L)  
 Osteomalacia 
o Poor indicators of vitamin D status:  
 Calcium, phosphate, alkaline phosphatase, PTH
17,18
  
4. Diagnostic imaging  
o Incidental finding on radiograph 
o Osteopenia/osteoporosis may suggest Vitamin D deficiency 
o Rickets/osteomalacia may be seen on X-ray 
 
Differential Diagnoses 
1. Vitamin D deficiency is established by serum testing 
2. See Risk factors for review of underlying causes  
 
Therapeutics 
1. Vitamin D replacement  
o Cholecalciferol (Vitamin D3) is preferred supplement (SOR:2C)  
o Severe deficiency - Treatment recommended (SOR:1A)  
 Treat with vitamin D 50,000 IU once per week for 6-8 weeks 
o Mild to moderate deficiency - Treatment recommended (SOR:2B) 
 Treat with vitamin D 800 - 1000 units / day and check levels in 3 
months 
 May need higher doses if inadequate response 
o Continue Vitamin D intake of 800 - 1000 units/day to maintain adequate 25 
OH Vit D 
o Vitamin D metabolites calcidiol or calcitriol may be required in patients with 
liver or renal disease  
 Calcidiol not available in the US 
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 Calcitriol used mainly in patients with chronic renal failure 
o Check levels 3 months after initiating treatment  
2. Precautions  
o Vitamin D toxicity has been noted at levels as low as 88 ng/ml  
 Hypercalcemia  
 Hypercalciuria 
o Calcitriol has rapid onset and half life of 6 hr  
 High incidence of hypercalcemia and patients should be monitored 
closely 
 
Prognosis 
1. No sequelae with proper treatment 
 
Prevention & Screening 
1. Prevention  
o Exposure to ultraviolet light of limited use as risks may outweigh benefits 
o Oral consumption of vitamin D 800-1000 units /day for adults (SOR:2B)  
o Infants  
 400 IU of Vitamin D daily beginning in 1st few days of life for all 
breast and formula fed infants 
 Formula fed infants will receive adequate Vitamin D if they consume 
>1 L of Vit D supplemented formula / day 
o Pregnancy and lactation  
 No current recommendation, but maternal vitamin D deficiency is a 
known risk factor for infant vitamin D deficiency 
 It is therefore reasonable to assess Vitamin D intake in pregnant and 
lactating mothers 
2. Screening  
o No recommendation for routine screening (SOR:2C)  
 
Patient Education 
1. http://www.webmd.com/diet/vitamins-supplements-8/supplement-guide-vitamin-d 
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